F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma

Clinical Nuclear Medicine

Volumn 36, Issue 12, 2011, Pages 1092-1097

  Wu, Hu Bing ^a   Wang, Quan Shi ^a   Li, Bao Yuan ^a   Li, Hong Sheng ^a   Zhou, Wen Lan ^a   Wang, Qiao Yu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

11C choline; computed tomography; diagnosis; F 18 FDG; hepatocellular carcinoma; positron emission tomography

Indexed keywords

CHOLINE C 11; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LIVER; LIVER CELL CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CARCINOMA, HEPATOCELLULAR; CHOLINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; WHOLE BODY IMAGING;

EID: 80955159778     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182335df4     Document Type: Article

References (28)

1. Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon. 2005;3:210-215. (Pubitemid 40932721)
2. Robinson P. Hepatocellular carcinoma: Development and early detection. Cancer Imaging. 2008;8:S128-S131.
3. Hayashida M, Ito K, Fujita T, et al. Small hepatocellular carcinomas in cirrhosis: Differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging. Magn Reson Imaging. 2008;26:65-71. (Pubitemid 350299721)
4. Maldonado A, González-Alenda FJ, Alonso M, et al. PET-CT in clinical oncology. Clin Transl Oncol. 2007;9:494-505.
5. Facey K, Bradbury I, Laking G, et al. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007;11:iii-iv, xi-267.
6. Wudel LJ Jr, Delbeke D, Morris D, et al. The role of-18F- fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg. 2003;69:117-124.
7. Ho CL, Yu SC, -eung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213-221.
8. Jeng LB, Changlai SP, Shen YY, et al. Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterology. 2003;50:2154-2156.
9. Yamamoto Y, Nishiyama Y, Kameyama R, et al. Detection of hepatocellular carcinoma using 11C-choline PET: Comparison with 18F-FDG PET. J Nucl Med. 2008;49:1245-1248.
10. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. (Pubitemid 43112690)
11. Wilson AA, Garcia G, Jin L, et al. Radiotracer synthesis from-11C-iodomethane: A remarkably simple captive solvent method. Nucl Med Biol. 2000;27:529-532.
12. Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885-895. (Pubitemid 46768453)
13. Kim YK, Lee KW, Cho SY, et al. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Liver Transpl. 2010;16:767-772.
14. Kawaoka T, Aikata H, Takaki S, et al. FDG positron emission tomography/ computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma. Hepatol Res. 2009;39:134-142.
15. Yoon KT, Kim JK, Kim do Y, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology. 2007;72: 104-110. (Pubitemid 350256673)
16. Yang SH, Suh KS, Lee HW, et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl. 2006;12:1655-1660. (Pubitemid 44742545)
17. Kornberg A, Küpper B, Thrum K, et al. Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patients. Transplant Proc. 2009;41:2561-2563.
18. Dierckx R, Maes A, Peeters M, et al. FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases. Q J Nucl Med Mol Imaging. 2009;53:336-342.
19. Seo S, Hatano E, Higashi T, et al. P-glycoprotein expression affects 18Ffluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Int J Oncol. 2009;34:1303-1312.
20. Paudyal B, Paudyal P, Oriuchi N, et al. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma. Int J Oncol. 2008;33:1047-1054.
21. Lee JD, Yang WI, Park YN, et al. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake. J Nucl Med. 2005;46:1753-1759. (Pubitemid 46211600)
22. Park JW, Kim JH, Kim SK, et al. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med. 2008;49:1912-1921.
23. Ho CL, Chen S, -eung DW, et al. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med. 2007;48:902-909. (Pubitemid 46909918)
24. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon- 11-choline. J Nucl Med. 1998;39:990-995. (Pubitemid 28270113)
25. Khan N, Oriuchi N, Ninomiya H, et al. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: Comparison with 18F-FDG PET. Ann Nucl Med. 2004;18:409-417. (Pubitemid 39265062)
26. Torizuka T, Kanno T, Futatsubashi M, et al. Imaging of gynecologic tumors: Comparison of (11)C-choline PET with (18)F-FDG PET. J Nucl Med. 2003; 44:1051-1056. (Pubitemid 39663379)
27. Yanagawa T, Watanabe H, Inoue T, et al. Carbon-11 choline positron emission tomography in musculoskeletal tumors: Comparison with fluorine- 18 fluorodeoxyglucose positron emission tomography. J Comput Assist Tomogr. 2003;27:175-182. (Pubitemid 37047214)
28. Reske SN, Blumstein NM, Neumaier B, et al. Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med. 2006;47:1249-1254. (Pubitemid 47544875)